AAAAAA

   
Results: 1-7 |
Results: 7
Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinityand selectivity for the dopamine D-3 receptor
Authors: Austin, NE Avenell, KY Boyfield, I Branch, CL Hadley, MS Jeffrey, P Johnson, CN Macdonald, GJ Nash, DJ Riley, GJ Smith, AB Stemp, G Thewlis, KM Vong, AKK Wood, MD
Citation: Ne. Austin et al., Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinityand selectivity for the dopamine D-3 receptor, BIOORG MED, 11(5), 2001, pp. 685-688
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D-3 receptor
Authors: Austin, NE Avenell, KY Boyfield, I Branch, CL Hadley, MS Jeffrey, P Johnson, CN Macdonald, GJ Nash, DJ Riley, GJ Smith, AB Stemp, G Thewlis, KM Vong, AKK Wood, M
Citation: Ne. Austin et al., Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 10(22), 2000, pp. 2553-2555
Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A
Authors: Reavill, C Taylor, SG Wood, MD Ashmeade, T Austin, NE Avenell, KY Boyfield, I Branch, CL Cilia, J Coldwell, MC Hadley, MS Hunter, AJ Jeffrey, P Jewitt, F Johnson, CN Jones, DNC Medhurst, AD Middlemiss, DN Nash, DJ Riley, GJ Routledge, C Stemp, G Thewlis, KM Trail, B Vong, AKK Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat
Authors: Stemp, G Ashmeade, T Branch, CL Hadley, MS Hunter, AJ Johnson, CN Nash, DJ Thewlis, KM Vong, AKK Austin, NE Jeffrey, P Avenell, KY Boyfield, I Hagan, JJ Middlemiss, DN Reavill, C Riley, GJ Routledge, C Wood, M
Citation: G. Stemp et al., Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J MED CHEM, 43(9), 2000, pp. 1878-1885
Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor
Authors: Wood, MD Boyfield, I Nash, DJ Jewitt, FR Avenell, KY Riley, GJ
Citation: Md. Wood et al., Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor, EUR J PHARM, 407(1-2), 2000, pp. 47-51
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D-3 receptor
Authors: Austin, NE Avenell, KY Boyfield, I Branch, CL Coldwell, MC Hadley, MS Jeffrey, P Johns, A Johnson, CN Nash, DJ Riley, GJ Smith, SA Stacey, RC Stemp, G Thewlis, KM Vong, AKK
Citation: Ne. Austin et al., Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(2), 1999, pp. 179-184
Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D-3 receptor
Authors: Avenell, KY Boyfield, I Hadley, MS Johnson, CN Nash, DJ Riley, GJ Stemp, G
Citation: Ky. Avenell et al., Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(18), 1999, pp. 2715-2720
Risultati: 1-7 |